Specifically, in the treatment of LHON, the expression of corrected copies of the ND4 gene using adeno-associated viral vectors (AAV) has led to a partial recovery of visual function in some patients carrying the m.11778G>A mutation. The gene discussed is MT-ND4; the disease is Leber hereditary optic neuropathy.